AI assistant
Sending…
LABCORP HOLDINGS INC. — Director's Dealing 2021
Feb 4, 2021
30237_dirs_2021-02-04_9f60e147-3b9b-47cd-ae20-20d4fb865019.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-02-02
Reporting Person: ANDERSON KERRII B (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-03 | Common Stock | G | 746 | — | Disposed | 18894 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-02 | Restricted Stock Unit | $ | A | 771 | Acquired | Common Stock (771) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 720 | Indirect |
Footnotes
F1: Amount reflects annuity payment of 480 shares made by the reporting person's grantor retained annuity trust to the reporting person on September 23, 2020.
F2: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F3: The Restricted Stock Units vest fully on February 2, 2022.
F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
More from LABCORP HOLDINGS INC.
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 4
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30
Director's Dealing
2026
Mar 30
Director's Dealing
2026
Mar 30